Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Morreau

Showing results (141-150 of 257) with videos related to

Pageof 26
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 25, 2013
Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancerTjalling Bosse, Natalja T ter Haar, Laura M Seeber, et al.
European Journal of Human Genetics : EJHG|May 18, 2018
Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriersIsaura Ibrahim, Babs G Sibinga Mulder, Bert Bonsing, et al.
BMC Cancer|January 16, 2007
A procedure for the detection of linkage with high density SNP arrays in a large pedigree with colorectal cancerAnneke Middeldorp, Shantie Jagmohan-Changur, Quinta Helmer, et al.
Gut|May 10, 2011
Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathwayLiudmila L Kodach, Rutger J Jacobs, Philip W Voorneveld, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2009
Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohortAnneke Middeldorp, Shantie Jagmohan-Changur, Ronald van Eijk, et al.
Endocrine Reviews|January 5, 2018
Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid NodulesElizabeth J de Koster, Lioe-Fee de Geus-Oei, Olaf M Dekkers, et al.
Thyroid : Official Journal of the American Thyroid Association|November 27, 2023
Molecular Diagnostics and [<sup>18</sup>F]FDG-PET/CT in Indeterminate Thyroid Nodules: Complementing Techniques or Waste of Valuable Resources?Elizabeth J de Koster, Hans Morreau, Gysele S Bleumink, et al.
Cancer Research|November 17, 2005
Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arraysEsther H Lips, Jan Willem F Dierssen, Ronald van Eijk, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 14, 2002
Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patientsAnand G Menon, Hans Morreau, Rob A E M Tollenaar, et al.
Biomarker Insights|July 11, 2017
Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal CellsSusanna Wl de Geus, Victor M Baart, Martin C Boonstra, et al.
Pageof 26

Showing results (141-150 of 257) with videos related to

Sort By:
Pageof 26
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 25, 2013
Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancerTjalling Bosse, Natalja T ter Haar, Laura M Seeber, et al.
European Journal of Human Genetics : EJHG|May 18, 2018
Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriersIsaura Ibrahim, Babs G Sibinga Mulder, Bert Bonsing, et al.
BMC Cancer|January 16, 2007
A procedure for the detection of linkage with high density SNP arrays in a large pedigree with colorectal cancerAnneke Middeldorp, Shantie Jagmohan-Changur, Quinta Helmer, et al.
Gut|May 10, 2011
Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathwayLiudmila L Kodach, Rutger J Jacobs, Philip W Voorneveld, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2009
Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohortAnneke Middeldorp, Shantie Jagmohan-Changur, Ronald van Eijk, et al.
Endocrine Reviews|January 5, 2018
Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid NodulesElizabeth J de Koster, Lioe-Fee de Geus-Oei, Olaf M Dekkers, et al.
Thyroid : Official Journal of the American Thyroid Association|November 27, 2023
Molecular Diagnostics and [<sup>18</sup>F]FDG-PET/CT in Indeterminate Thyroid Nodules: Complementing Techniques or Waste of Valuable Resources?Elizabeth J de Koster, Hans Morreau, Gysele S Bleumink, et al.
Cancer Research|November 17, 2005
Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arraysEsther H Lips, Jan Willem F Dierssen, Ronald van Eijk, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 14, 2002
Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patientsAnand G Menon, Hans Morreau, Rob A E M Tollenaar, et al.
Biomarker Insights|July 11, 2017
Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal CellsSusanna Wl de Geus, Victor M Baart, Martin C Boonstra, et al.
Pageof 26